Friday, April 13, 2012

Diuretics

Diuretics - regulate ECW - via diuresis and natriuresis

Site I = proximal tubule
  • acetazolamine (Diamox)
    • blocks CA
    • decreases H+ secretion
    • decreases Na+ reabsorption
    • increases Na+ load at distal tubule (stimulates Na-K antiporter = K loss
    • increases HCO3- excretion (corrects respiratory alkalosis from hypoxia-induced hyperventilation by causing metabolic acidosis; useful in high altitude) 
Sites 1-5

  • Osmotic diuretics; e.g., mannitol - held in tubule
    • expand ECF
    • increase diuresis and natriuresis
    • used to reduce intraocular pressure 

Site 2 (loop of Henle)
  • Furosemide (lasix)
    • increased Na, Cl delivery to macula densa: tubuloglomerular feedback = senses increased GFR. macula densa (epithelial cells) release substance (maybe adenosine) that causes afferent vasconstriction. also MD inhibit granular cells release of renin (less AT2) efferent vasodilation.  result = decreased GFR.

    • used in CHF, cirrhosis - reduce edema
    • side effects
      • hypotension
      • hyponatremia
      • hypokalemia
Site 3 (distal tubule)
  • Thiazides
    • increase Na, Cl excretion
    • inhibits Na Cl cotransporter in luminal membrane
    • increases Na delivery to late distal tubule = Na reabsorption & K loss 
    •  side effects
      • hypotension
      • hyponatremia
      • hypokalemia
      • decrease insulin sensitivity
 Site 4 (late distal tubule and CD)
  • Na channel inhibitors; e.g., amilioride
    • inhibit luminal Na channels - prevents Na reabsorption and K loss
    • reduce H excretion (block Na - H antiporter)
    • side effects
      • hyperkalemia
      • metabolic acidosis
  • Aldosterone antagonists; e.g., spironolactone; eplerenone (more selective)
    • block luminal Na channel
    • decrease Na-K ATPase
    • side effects
      • hyponatremia
      • hyperkalemia
      • metabolic acidosis
      • antiandrogenic effects (menstrual irreg.  gynecomastia)

Site 5 (collecting duct)

  • Vasopressin antagonists; e.g., conivaptin (iv) tolvaptin (oral)
  • block AVP binding to V2 receptors
  • side effects
    • dry mouth, thirst
    • nephrogenic diabetes insipidus (excess water loss)

No comments: